PRISM BioLab > ニュース > Anti-tumor activity of the small molecule inhibitor PRI-724 against β-catenin-activated hepatocellular carcinoma

Anti-tumor activity of the small molecule inhibitor PRI-724 against β-catenin-activated hepatocellular carcinoma

Published on: 9月 8, 2021

Japanese

ニュース